Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Leukocyte Antigen–G and Cancer Immunoediting
Mirjana Urosevic, Reinhard Dummer
Cancer Research (2008) Vol. 68, Iss. 3, pp. 627-630
Open Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression
Xiang-Juan Li, Xia Zhang, Aifen Lin, et al.
Human Immunology (2012) Vol. 73, Iss. 9, pp. 946-949
Closed Access | Times Cited: 66
Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer
Jinbao Sun, Haipeng Chu, Jianghai Ji, et al.
International Journal of Oncology (2016) Vol. 49, Iss. 3, pp. 943-952
Open Access | Times Cited: 60
Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines
Irene Fernández‐Delgado, Diego Calzada‐Fraile, Francisco Sánchez‐Madrid
Cancers (2020) Vol. 12, Iss. 12, pp. 3558-3558
Open Access | Times Cited: 48
Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients
Philipp Schütt, Birgit Schütt, Magdalena Switala, et al.
Human Immunology (2010) Vol. 71, Iss. 5, pp. 489-495
Closed Access | Times Cited: 66
Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancer
Aifen Lin, Chengsong Zhu, H.‐X. Chen, et al.
Journal of Cellular and Molecular Medicine (2009) Vol. 14, Iss. 9, pp. 2318-2329
Open Access | Times Cited: 59
Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma
Aifen Lin, Xia Zhang, Wenjun Zhou, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 6, pp. 1382-1390
Open Access | Times Cited: 58
Elevation of plasma soluble human leukocyte antigen–G in patients with chronic hepatitis C virus infection
Peng-jian Weng, Yan-Min Fu, Shi-Xiong Ding, et al.
Human Immunology (2011) Vol. 72, Iss. 5, pp. 406-411
Closed Access | Times Cited: 53
Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV‐induced usual vulvar intraepithelial neoplasia and implications for immunotherapy
Edith M.G. van Esch, Bart Tummers, V. Baartmans, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 4, pp. 830-842
Open Access | Times Cited: 43
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors
Jacek R. Wilczyński, Marek Nowak
Experientia supplementum (2022), pp. 1-57
Closed Access | Times Cited: 19
Correlation of Human Leukocyte Antigen-G (HLA-G) Expression and Disease Progression in Epithelial Ovarian Cancer
Yong Wook Jung, Young Tae Kim, Sang Wun Kim, et al.
Reproductive Sciences (2009) Vol. 16, Iss. 11, pp. 1103-1111
Closed Access | Times Cited: 54
Human Leukocyte Antigen-G (HLA-G) Expression in Cervical Lesions: Association With Cancer Progression, HPV 16/18 Infection, and Host Immune Response
Dandan Dong, Hong Yang, Ke Li, et al.
Reproductive Sciences (2010) Vol. 17, Iss. 8, pp. 718-723
Closed Access | Times Cited: 52
Human Leukocyte Antigen G Expression in Breast Cancer: Role in Immunosuppression
Robert L. Elliott, Xian Jiang, Jeffrey Phillips, et al.
Cancer Biotherapy and Radiopharmaceuticals (2011) Vol. 26, Iss. 2, pp. 153-157
Closed Access | Times Cited: 43
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition
Michael Campoli, Soldano Ferrone
Seminars in Immunopathology (2011) Vol. 33, Iss. 4, pp. 321-334
Open Access | Times Cited: 42
HLA‐G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer
Aifen Lin, Xia Zhang, Huihui Xu, et al.
International Journal of Cancer (2011) Vol. 131, Iss. 1, pp. 150-157
Closed Access | Times Cited: 41
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease?
Angela Dardano, Roberta Rizzo, Antonio Polini, et al.
The Journal of Clinical Endocrinology & Metabolism (2012) Vol. 97, Iss. 11, pp. 4080-4086
Open Access | Times Cited: 39
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?
Fabrícia Gimenes, Jorge Juarez Vieira Teixeira, André Luelsdorf Pimenta de Abreu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 576-589
Closed Access | Times Cited: 35
The Immune Microenvironment in Basal Cell Carcinoma
Catherine Zilberg, J. Guy Lyons, Ruta Gupta, et al.
Annals of Dermatology (2023) Vol. 35, Iss. 4, pp. 243-243
Open Access | Times Cited: 10
LILRB1 polymorphism and surface phenotypes of natural killer cells
Chelsea L. Davidson, Nicholas L. Li, Deborah N. Burshtyn
Human Immunology (2010) Vol. 71, Iss. 10, pp. 942-949
Closed Access | Times Cited: 38
New Insights into HLA-G and Inflammatory Diseases
Roberta Rizzo, Daria Bortolotti, Olavio R. Baricordi, et al.
Inflammation & Allergy - Drug Targets (2012) Vol. 11, Iss. 6, pp. 448-463
Closed Access | Times Cited: 36
Classic and Nonclassic HLA Class I Expression in Penile Cancer and Relation to HPV Status and Clinical Outcome
Rosa S. Djajadiningrat, Simon Horenblas, Daniëlle A.M. Heideman, et al.
The Journal of Urology (2014) Vol. 193, Iss. 4, pp. 1245-1251
Open Access | Times Cited: 31
Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression
Dorian A. Stolk, Hans van Vliet, Tanja D. de Gruijl, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 31
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells
Rachel A. Burga, Nguyễn Tường Vân, Jane Zulovich, et al.
Cytotherapy (2016) Vol. 18, Iss. 11, pp. 1410-1421
Open Access | Times Cited: 29
Low Expression of Human Histocompatibility Soluble Leukocyte Antigen-G (HLA-G5) in Invasive Cervical Cancer With and Without Metastasis, Associated With Papilloma Virus (HPV)
Márcia Cristina Guimarães, Christiane Pienna Soares, Eduardo Antônio Donadi, et al.
Journal of Histochemistry & Cytochemistry (2009) Vol. 58, Iss. 5, pp. 405-411
Open Access | Times Cited: 37
Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy
Mohamed Shehata, Abhik Mukherjee, Suha Deen, et al.
British Journal of Cancer (2009) Vol. 101, Iss. 8, pp. 1321-1328
Open Access | Times Cited: 33
Cancer: Tumor Iron Metabolism, Mitochondrial Dysfunction and Tumor Immunosuppression; “A Tight Partnership—Was Warburg Correct?”
Robert L. Elliott, Jonathan F. Head
Journal of Cancer Therapy (2012) Vol. 03, Iss. 04, pp. 278-311
Open Access | Times Cited: 29

Scroll to top